Table 1.
Lipid subcomponent | 2002 NCEP-ATP III3 | 2011 ESC4 | 2016 ESC5 | 2019 ESC6 |
---|---|---|---|---|
LDL-C | ≥25% reduction from baseline, and <2.6 mmol/L | ≥50% reduction from baseline, and <1.8 mmol/L | ≥50% reduction from baseline <1.8 mmol/L | ≥50% reduction from baseline <1.4 mmol/L |
Percentage of patients with lifetime average levels below recommended LDL-C threshold | 81.9% | 24.3% | 24.3% | 5.8% |
Non–HDL-C | No specific goal | No specific goal | No specific goal | <2.2 mmol/L |
TG | No specific goal | No specific goal | No specific goal | No specific goal Aim <1.7 mmol/L |
TC | No specific goal | No specific goal | No specific goal | No specific goal |
NCEP-ATP III, National Cholesterol Education Program Adult Treatment Panel III; ESC, European Society of Cardiology; LDL-C, low-density lipoprotein cholesterol; non–HDL-C, non–high-density lipoprotein cholesterol; TG, triglycerides; TC, total cholesterol.